Convergent functional genomic studies of omega-3 fatty acids in stress reactivity, bipolar disorder and alcoholism

Translational Psychiatry

Volumn 1, Issue , 2011, Pages

  Le Niculescu, H ^a   Case, N J ^a   Hulvershorn, L ^a   Patel, S D ^a,c   Bowker, D ^a   Gupta, J ^a   Bell, R ^a   Edenberg, H J ^a   Tsuang, M T ^b   Kuczenski, R ^b   Geyer, M A ^b   Rodd, Z A ^a   Niculescu, A B ^a,c  

^a INDIANA UNIVERSITY   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Alcoholism; Bipolar; DHA; Genomics; Omega 3; Stress

Indexed keywords

DOCOSAHEXAENOIC ACID;

ALCOHOLISM; ANIMAL; ANIMAL BEHAVIOR; ARTICLE; BIPOLAR DISORDER; BLOOD; COMPARATIVE STUDY; DISEASE MODEL; DRUG EFFECT; FEMALE; GENETICS; GENOMICS; HUMAN; MALE; MENTAL STRESS; METHODOLOGY; MOUSE; MOUSE MUTANT; PHYSIOLOGY; RAT; TRANSGENIC MOUSE;

ALCOHOLISM; ANIMALS; BEHAVIOR, ANIMAL; BIPOLAR DISORDER; DISEASE MODELS, ANIMAL; DOCOSAHEXAENOIC ACIDS; FEMALE; GENOMICS; HUMANS; MALE; MICE; MICE, KNOCKOUT; MICE, TRANSGENIC; RATS; STRESS, PSYCHOLOGICAL;

EID: 79958101468     PISSN: None     EISSN: 21583188     Source Type: Journal    
DOI: 10.1038/tp.2011.1     Document Type: Article

References (221)

1. Cunnane SC, Crawford MA. Survival of the fattest: fat babies were the key to evolution of the large human brain. Comp Biochem Physiol A Mol Integr Physiol 2003;136:17-26. (Pubitemid 37289403)
2. Simopoulos AP. Evolutionary aspects of diet, the omega-6/omega-3 ratio and genetic variation: nutritional implications for chronic diseases. Biomed Pharmacother 2006;60:502-507. (Pubitemid 44635081)
3. DeMar Jr JC, Ma K, Bell JM, Igarashi M, Greenstein D, Rapoport SI. One generation of n-3 polyunsaturated fatty acid deprivation increases depression and aggression test scores in rats. J Lipid Res 2006;47:172-180. (Pubitemid 43107460)
4. Rao JS, Ertley RN, Lee HJ, DeMar Jr JC, Arnold JT, Rapoport SI et al. n-3 polyunsaturated fatty acid deprivation in rats decreases frontal cortex BDNF via a p38 MAPK-dependent mechanism. Mol Psychiatry 2007;12:36-46. (Pubitemid 44973661)
5. Zanarini MC, Frankenburg FR. Omega-3 Fatty acid treatment of women with borderline personality disorder: a double-blind, placebo-controlled pilot study. Am J Psychiatry 2003;160:167-169. (Pubitemid 36042442)
6. Lin PY, Huang SY, Su KP. A meta-analytic review of polyunsaturated fatty acid compositions in patients with depression. Biol Psychiatry 2010;68:140-147.
7. McNamara RK. DHA deficiency and prefrontal cortex neuropathology in recurrent affective disorders. J Nutr 2010;140:864-868.
8. McNamara RK, Jandacek R, Rider T, Tso P, Stanford KE, Hahn CG et al. Deficits in docosahexaenoic acid and associated elevations in the metabolism of arachidonic acid and saturated fatty acids in the postmortem orbitofrontal cortex of patients with bipolar disorder. Psychiatry Res 2008;160:285-299.
9. Stoll AL, Severus WE, Freeman MP, Rueter S, Zboyan HA, Diamond E et al. Omega 3 fatty acids in bipolar disorder: a preliminary double-blind, placebo-controlled trial. Arch Gen Psychiatry 1999;56:407-412. (Pubitemid 29215428)
10. Parker G, Gibson NA, Brotchie H, Heruc G, Rees AM, Hadzi-Pavlovic D. Omega-3 fatty acids and mood disorders. Am J Psychiatry 2006;163:969-978. (Pubitemid 44464482)
11. Osher Y, Belmaker RH. Omega-3 fatty acids in depression: a review of three studies. CNS Neurosci Ther 2009;15:128-133.
12. Clayton EH, Hanstock TL, Hirneth SJ, Kable CJ, Garg ML, Hazell PL. Reduced mania and depression in juvenile bipolar disorder associated with long-chain omega-3 polyunsaturated fatty acid supplementation. Eur J Clin Nutr 2009;63:1037-1040.
13. Peet M, Stokes C. Omega-3 fatty acids in the treatment of psychiatric disorders. Drugs 2005;65:1051-1059. (Pubitemid 40840003)
14. Berger GE, Wood SJ, Wellard RM, Proffitt TM, McConchie M, Amminger GP et al. Ethyl-eicosapentaenoic acid in first-episode psychosis. A 1H-MRS study. Neuropsychopharmacology 2008;33:2467-2473.
15. Amminger GP, Schafer MR, Papageorgiou K, Klier CM, Cotton SM, Harrigan SM et al. Long-chain omega-3 fatty acids for indicated prevention of psychotic disorders: a randomized, placebo-controlled trial. Arch Gen Psychiatry 2010;67:146-154.
16. Farzaneh-Far R, Lin J, Epel ES, Harris WS, Blackburn EH, Whooley MA. Association of marine omega-3 fatty acid levels with telomeric aging in patients with coronary heart disease. JAMA 2010;303:250-257.
17. Muldoon MF, Ryan CM, Sheu L, Yao JK, Conklin SM, Manuck SB. Serum phospholipid docosahexaenonic acid is associated with cognitive functioning during middle adulthood. J Nutr 2010;140:848-853.
18. Green KN, Martinez-Coria H, Khashwji H, Hall EB, Yurko-Mauro KA, Ellis L et al. Dietary docosahexaenoic acid and docosapentaenoic acid ameliorate amyloid-beta and tau pathology via a mechanism involving presenilin 1 levels. J Neurosci 2007;27:4385-4395. (Pubitemid 46640724)
19. Niculescu III AB, Segal DS, Kuczenski R, Barrett T, Hauger RL, Kelsoe JR. Identifying a series of candidate genes for mania and psychosis: a convergent functional genomics approach. Physiol Genomics 2000;4:83-91. (Pubitemid 33676684)
20. Rodd ZA, Bertsch BA, Strother WN, Le-Niculescu H, Balaraman Y, Hayden E et al. Candidate genes, pathways and mechanisms for alcoholism: an expanded convergent functional genomics approach. Pharmacogenomics J 2007;7:222-256. (Pubitemid 47207752)
21. Le-Niculescu H, Balaraman Y, Patel S, Tan J, Sidhu K, Jerome RE et al. Towards understanding the schizophrenia code: an expanded convergent functional genomics approach. Am J Med Genet B Neuropsychiatr Genet 2007;144:129-158. (Pubitemid 46606639)
22. Le-Niculescu H, McFarland M, Ogden C, Balaraman Y, Patel S, Tan J et al. Phenomic, convergent functional genomic, and biomarker studies in a stress-reactive genetic animal model of bipolar disorder and co-morbid alcoholism. Am J Med Genet B 2008;147 B: 134-166. (Pubitemid 351355275)
23. Niculescu AB, Le-Niculescu H. The P-value illusion: how to improve (psychiatric) genetic studies. Am J Med Genet B Neuropsychiatr Genet 2010;153 B: 847-849.
24. Schuckit MA, Smith TL, Chacko Y. Evaluation of a depression-related model of alcohol problems in 430 probands from the San Diego prospective study. Drug Alcohol Depend 2006;82:194-203.
25. Kuo PH, Gardner CO, Kendler KS, Prescott CA. The temporal relationship of the onsets of alcohol dependence and major depression: using a genetically informative study design. Psychol Med 2006;36:1153-1162. (Pubitemid 44084018)
26. Nurnberger Jr JI, Wiegand R, Bucholz K, O'Connor S, Meyer ET, Reich T et al. A family study of alcohol dependence: coaggregation of multiple disorders in relatives of alcoholdependent probands. Arch Gen Psychiatry 2004;61:1246-1256. (Pubitemid 39602841)
27. Lim GP, Calon F, Morihara T, Yang F, Teter B, Ubeda O et al. A diet enriched with the omega-3 fatty acid docosahexaenoic acid reduces amyloid burden in an aged Alzheimer mouse model. J Neurosci 2005;25:3032-3040. (Pubitemid 40463537)
28. Niculescu AB, Lulow LL, Ogden CA, Le-Niculescu H, Salomon DR, Schork NJ et al. PhenoChipping of psychotic disorders: a novel approach for deconstructing and quantitating psychiatric phenotypes. Am J Med Genet B Neuropsychiatr Genet 2006;141:653-662. (Pubitemid 44434667)
29. Ogden CA, Rich ME, Schork NJ, Paulus MP, Geyer MA, Lohr JB et al. Candidate genes, pathways and mechanisms for bipolar (manic-depressive) and related disorders: an expanded convergent functional genomics approach. Mol Psychiatry 2004;9:1007-1029. (Pubitemid 39524290)
30. Le-Niculescu H, Kurian SM, Yehyawi N, Dike C, Patel SD, Edenberg HJ et al. Identifying blood biomarkers for mood disorders using convergent functional genomics. Mol Psychiatry 2009;14:156-174.
31. Kurian SM, Le-Niculescu H, Patel SD, Bertram D, Davis J, Dike C et al. Identification of blood biomarkers for psychosis using convergent functional genomics. Mol Psychiatry 2011;16:37-58.
32. Monteggia LM, Luikart B, Barrot M, Theobold D, Malkovska I, Nef S et al. Brain-derived neurotrophic factor conditional knockouts show gender differences in depression-related behaviors. Biol Psychiatry 2007;61:187-197. (Pubitemid 46072778)
33. Niculescu AB, Akiskal HS. Sex hormones, Darwinism, and depression. Arch Gen Psychiatry 2001;58:1083-1084; author reply 5-6.
34. Niculescu III AB, Akiskal HS. Proposed endophenotypes of dysthymia: evolutionary, clinical and pharmacogenomic considerations. Mol Psychiatry 2001;6:363-366. (Pubitemid 32566083)
35. Patel SD, Le-Niculescu H, Koller DL, Green SD, Lahiri DK, McMahon FJ et al. Coming to grips with complex disorders: genetic risk prediction in bipolar disorder using panels of genes identified through convergent functional genomics. Am J Med Genet B Neuropsychiatr Genet 2010;153 B: 850-877.
36. Vawter MP, Tomita H, Meng F, Bolstad B, Li J, Evans S et al. Mitochondrial-related gene expression changes are sensitive to agonal-pH state: implications for brain disorders. Mol Psychiatry 2006;11:615, 663-679. (Pubitemid 43989805)
37. O'Brien WT, Klein PS. Validating GSK3 as an in vivo target of lithium action. Biochem Soc Trans 2009;37(Pt 5):1133-1138.
38. Svenningsson P, Tzavara ET, Carruthers R, Rachleff I, Wattler S, Nehls M et al. Diverse psychotomimetics act through a common signaling pathway. Science 2003;302:1412-1415. (Pubitemid 37452186)
39. Perlis RH, Smoller JW, Ferreira MA, McQuillin A, Bass N, Lawrence J et al. A genomewide association study of response to lithium for prevention of recurrence in bipolar disorder. Am J Psychiatry 2009;166:718-725.
40. Benes FM, Lim B, Matzilevich D, Subburaju S, Walsh JP. Circuitry-based gene expression profiles in GABA cells of the trisynaptic pathway in schizophrenics versus bipolars. Proc Natl Acad Sci USA 2008;105:20935-20940.
41. Sequeira A, Mamdani F, Ernst C, Vawter MP, Bunney WE, Lebel V et al. Global brain gene expression analysis links glutamatergic and GABAergic alterations to suicide and major depression. PLoS One 2009;4:e6585.
42. Rao JS, Harry GJ, Rapoport SI, Kim HW. Increased excitotoxicity and neuroinflammatory markers in postmortem frontal cortex from bipolar disorder patients. Mol Psychiatry 2010;15:384-392.
43. Segman RH, Shefi N, Goltser-Dubner T, Friedman N, Kaminski N, Shalev AY. Peripheral blood mononuclear cell gene expression profiles identify emergent post-traumatic stress disorder among trauma survivors. Mol Psychiatry 2005;10:500-513, 425. (Pubitemid 40646438)
44. Morita K, Saito T, Ohta M, Ohmori T, Kawai K, Teshima-Kondo S et al. Expression analysis of psychological stress-associated genes in peripheral blood leukocytes. Neurosci Lett 2005;381:57-62. (Pubitemid 40703902)
45. Horiuchi Y, Nakayama J, Ishiguro H, Ohtsuki T, Detera-Wadleigh SD, Toyota T et al. Possible association between a haplotype of the GABA-A receptor alpha 1 subunit gene (GABRA1) and mood disorders. Biol Psychiatry 2004;55:40-45. (Pubitemid 38045431)
46. Breuer R, Hamshere ML, Strohmaier J, Mattheisen M, Degenhardt F, Meier S et al. Independent evidence for the selective influence of GABA (A) receptors on one component of the bipolar disorder phenotype. Mol Psychiatry; advance online publication, 15 June 2010 [e-pub ahead of print].
47. Donner J, Pirkola S, Silander K, Kananen L, Terwilliger JD, Lonnqvist J et al. An association analysis of murine anxiety genes in humans implicates novel candidate genes for anxiety disorders. Biol Psychiatry 2008;64:672-680.
48. Begemann M, Sargin D, Rossner MJ, Bartels C, Theis F, Wichert SP et al. Episode-specific differential gene expression of peripheral blood mononuclear cells in rapid cycling supports novel treatment approaches. Mol Med 2008;14:546-552.
49. Lee KW, Lee SH, Kim H, Song JS, Yang SD, Paik SG et al. Progressive cognitive impairment and anxiety induction in the absence of plaque deposition in C57BL/6 inbred mice expressing transgenic amyloid precursor protein. J Neurosci Res 2004;76:572-580. (Pubitemid 38580472)
50. Reyes TM, Walker JR, DeCino C, Hogenesch JB, Sawchenko PE. Categorically distinct acute stressors elicit dissimilar transcriptional profiles in the paraventricular nucleus of the hypothalamus. J Neurosci 2003;23:5607-5616. (Pubitemid 36807838)
51. Tkachev D, Mimmack ML, Ryan MM, Wayland M, Freeman T, Jones PB et al. Oligodendrocyte dysfunction in schizophrenia and bipolar disorder. Lancet 2003;362:798-805. (Pubitemid 37093922)
52. Haroutunian V, Katsel P, Dracheva S, Stewart DG, Davis KL. Variations in oligodendrocyte-related gene expression across multiple cortical regions: implications for the pathophysiology of schizophrenia. Int J Neuropsychopharmacol 2007;10:565-573. (Pubitemid 46985258)
53. McGrath CL, Glatt SJ, Sklar P, Le-Niculescu H, Kuczenski R, Doyle AE et al. Evidence for genetic association of RORB with bipolar disorder. BMC Psychiatry 2009;9:70.
54. Basselin M, Kim HW, Chen M, Ma K, Rapoport SI, Murphy RC et al. Lithium modifies brain arachidonic and docosahexaenoic metabolism in rat lipopolysaccharide model of neuroinflammation. J Lipid Res 2010;51:1049-1056.
55. Ostacher MJ, Perlis RH, Nierenberg AA, Calabrese J, Stange JP, Salloum I et al. Impact of substance use disorders on recovery from episodes of depression in bipolar disorder patients: prospective data from the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD). Am J Psychiatry 2010;167:289-297.
56. Shaldubina A, Einat H, Szechtman H, Shimon H, Belmaker RH. Preliminary evaluation of oral anticonvulsant treatment in the quinpirole model of bipolar disorder. J Neural Transm 2002;109:433-440. (Pubitemid 34251645)
57. Gould TD, Einat H, Bhat R, Manji HK. AR-A014418, a selective GSK-3 inhibitor, produces antidepressant-like effects in the forced swim test. Int J Neuropsychopharmacol 2004;7:387-390. (Pubitemid 39648068)
58. Einat H, Manji HK, Gould TD, Du J, Chen G. Possible involvement of the ERK signaling cascade in bipolar disorder: behavioral leads from the study of mutant mice. Drug News Perspect 2003;16:453-463. (Pubitemid 37442423)
59. Einat H, Manji HK. Cellular plasticity cascades: genes-to-behavior pathways in animal models of bipolar disorder. Biol Psychiatry 2006;59:1160-1171. (Pubitemid 43949143)
60. Einat H. Establishment of a battery of simple models for facets of bipolar disorder: a practical approach to achieve increased validity, better screening and possible insights into endophenotypes of disease. Behav Genet 2007;37:244-255. (Pubitemid 46144059)
61. Roybal K, Theobold D, Graham A, DiNieri JA, Russo SJ, Krishnan V et al. Mania-like behavior induced by disruption of CLOCK. Proc Natl Acad Sci USA 2007;104:6406-6411. (Pubitemid 47186107)
62. Chen G, Henter ID, Manji HK. Translational research in bipolar disorder: emerging insights from genetically based models. Mol Psychiatry 2010;15:883-895.
63. Gould TD, O'Donnell KC, Picchini AM, Dow ER, Chen G, Manji HK. Generation and behavioral characterization of beta-catenin forebrain-specific conditional knock-out mice. Behav Brain Res 2008;189:117-125.
64. Kubota M, Kasahara T, Iwamoto K, Komori A, Ishiwata M, Miyauchi T et al. Therapeutic implications of down-regulation of cyclophilin D in bipolar disorder. Int J Neuropsychopharmacol 2010;13:1355-1368.
65. Kasahara T, Kubota M, Miyauchi T, Noda Y, Mouri A, Nabeshima T et al. Mice with neuron-specific accumulation of mitochondrial DNA mutations show mood disorder-like phenotypes. Mol Psychiatry 2006;11:577-593, 523.
66. Lavebratt C, Sjoholm LK, Partonen T, Schalling M, Forsell Y. PER2 variantion is associated with depression vulnerability. Am J Med Genet B Neuropsychiatr Genet 2010;153 B: 570-581.
67. Lavebratt C, Sjoholm LK, Soronen P, Paunio T, Vawter MP, Bunney WE et al. CRY2 is associated with depression. PLoS One 2010;5:e9407.
68. Sjoholm LK, Kovanen L, Saarikoski ST, Schalling M, Lavebratt C, Partonen T. CLOCK is suggested to associate with comorbid alcohol use and depressive disorders. J Circadian Rhythms 2010;8:1.
69. Bunney Jr WE, Murphy DL, Goodwin FK, Borge GF. The "switch process" in manicdepressive illness. I. A systematic study of sequential behavioral changes. Arch Gen Psychiatry 1972;27:295-302.
70. Koob GF. The neurobiology of addiction: a neuroadaptational view relevant for diagnosis. Addiction 2006;101(Suppl 1):23-30. (Pubitemid 44199493)
71. Niculescu III AB. Polypharmacy in oligopopulations: what psychiatric genetics can teach biological psychiatry. Psychiatr Genet 2006;16:241-244. (Pubitemid 44760303)
72. Sommer W, Arlinde C, Heilig M. The search for candidate genes of alcoholism: evidence from expression profiling studies. Addict Biol 2005;10:71-79.
73. Sugawara H, Iwamoto K, Bundo M, Ishiwata M, Ueda J, Kakiuchi C et al. Effect of mood stabilizers on gene expression in lymphoblastoid cells. J Neural Transm 2010;117:155-164.
74. Lewis CM, Ng MY, Butler AW, Cohen-Woods S, Uher R, Pirlo K et al. Genome-wide association study of major recurrent depression in the U. K. population. Am J Psychiatry 2010;167:949-957.
75. Szczepankiewicz A, Skibinska M, Hauser J, Slopien A, Leszczynska- Rodziewicz A, Kapelski P et al. Association analysis of the GSK-3beta T-50C gene polymorphism with schizophrenia and bipolar disorder. Neuropsychobiology 2006;53:51-56. (Pubitemid 43254178)
76. Lachman HM, Pedrosa E, Petruolo OA, Cockerham M, Papolos A, Novak T et al. Increase in GSK3beta gene copy number variation in bipolar disorder. Am J Med Genet B Neuropsychiatr Genet 2007;144 B: 259-265. (Pubitemid 46642013)
77. Kalscheuer VM, Musante L, Fang C, Hoffmann K, Fuchs C, Carta E et al. A balanced chromosomal translocation disrupting ARHGEF9 is associated with epilepsy, anxiety, aggression, and mental retardation. Hum Mutat 2009;30:61-68.
78. Kaabi B, Gelernter J, Woods SW, Goddard A, Page GP, Elston RC. Genome scan for loci predisposing to anxiety disorders using a novel multivariate approach: strong evidence for a chromosome 4 risk locus. Am J Hum Genet 2006;78:543-553.
79. Gaiteri C, Guilloux JP, Lewis DA, Sibille E. Altered gene synchrony suggests a combined hormone-mediated dysregulated state in major depression. PLoS One 2010;5:e9970.
80. Thibault C, Lai C, Wilke N, Duong B, Olive MF, Rahman S et al. Expression profiling of neural cells reveals specific patterns of ethanol-responsive gene expression. Mol Pharmacol 2000;58:1593-1600.
81. Cichon S, Schumacher J, Muller DJ, Hurter M, Windemuth C, Strauch K et al. A genome screen for genes predisposing to bipolar affective disorder detects a new susceptibility locus on 8q. Hum Mol Genet 2001;10:2933-2944. (Pubitemid 34030924)
82. Del Zompo M, Severino G, Ardau R, Chillotti C, Piccardi M, Dib C et al. Genome-scan for bipolar disorder with sib-pair families in the Sardinian population: a new susceptibility locus on chromosome 1p22-p21? Am J Med Genet B Neuropsychiatr Genet 2010;153 B: 1200-1208.
83. Edenberg HJ, Koller DL, Xuei X, Wetherill L, McClintick JN, Almasy L et al. Genome-wide association study of alcohol dependence implicates a region on chromosome 11. Alcohol Clin Exp Res 2010;34:840-852.
84. Bell RL, Kimpel MW, McClintick JN, Strother WN, Carr LG, Liang T et al. Gene expression changes in the nucleus accumbens of alcohol-preferring rats following chronic ethanol consumption. Pharmacol Biochem Behav 2009;94:131-147.
85. Sokolov BP, Jiang L, Trivedi NS, Aston C. Transcription profiling reveals mitochondrial, ubiquitin and signaling systems abnormalities in postmortem brains from subjects with a history of alcohol abuse or dependence. J Neurosci Res 2003;72:756-767. (Pubitemid 36666269)
86. Etain B, Mathieu F, Rietschel M, Maier W, Albus M, McKeon P et al. Genome-wide scan for genes involved in bipolar affective disorder in 70 European families ascertained through a bipolar type I early-onset proband: supportive evidence for linkage at 3p14. Mol Psychiatry 2006;11:685-694. (Pubitemid 43989815)
87. Segman RH, Goltser-Dubner T, Weiner I, Canetti L, Galili-Weisstub E, Milwidsky A et al. Blood mononuclear cell gene expression signature of postpartum depression. Mol Psychiatry 2010;15:93-100, 2.
88. Sklar P, Pato MT, Kirby A, Petryshen TL, Medeiros H, Carvalho C et al. Genome-wide scan in Portuguese Island families identifies 5q31-5q35 as a susceptibility locus for schizophrenia and psychosis. Mol Psychiatry 2004;9:213-218. (Pubitemid 38299537)
89. Hong KS, McInnes LA, Service SK, Song T, Lucas J, Silva S et al. Genetic mapping using haplotype and model-free linkage analysis supports previous evidence for a locus predisposing to severe bipolar disorder at 5q31-33. Am J Med Genet B Neuropsychiatr Genet 2004;125 B: 83-86. (Pubitemid 38141409)
90. Crowe RR, Goedken R, Samuelson S, Wilson R, Nelson J, Noyes Jr R. Genomewide survey of panic disorder. Am J Med Genet 2001;105:105-109.
91. Mukherjee S, Coque L, Cao JL, Kumar J, Chakravarty S, Asaithamby A et al. Knockdown of clock in the ventral tegmental area through RNA interference results in a mixed state of mania and depression-like behavior. Biol Psychiatry 2010;68:503-511.
92. Torrey EF, Barci BM, Webster MJ, Bartko JJ, Meador-Woodruff JH, Knable MB. Neurochemical markers for schizophrenia, bipolar disorder, and major depression in postmortem brains. Biol Psychiatry 2005;57:252-260. (Pubitemid 40187369)
93. Noble EP, Blum K, Ritchie T, Montgomery A, Sheridan PJ. Allelic association of the D2 dopamine receptor gene with receptor-binding characteristics in alcoholism. Arch Gen Psychiatry 1991;48:648-654.
94. Kraschewski A, Reese J, Anghelescu I, Winterer G, Schmidt LG, Gallinat J et al. Association of the dopamine D2 receptor gene with alcohol dependence: haplotypes and subgroups of alcoholics as key factors for understanding receptor function. Pharmacogenet Genomics 2009;19:513-527.
95. Munafo MR, Matheson IJ, Flint J. Association of the DRD2 gene Taq1A polymorphism and alcoholism: a meta-analysis of case-control studies and evidence of publication bias. Mol Psychiatry 2007;12:454-461. (Pubitemid 46652456)
96. Smith L, Watson M, Gates S, Ball D, Foxcroft D. Meta-analysis of the association of the Taq1A polymorphism with the risk of alcohol dependency: a HuGE gene-disease association review. Am J Epidemiol 2008;167:125-138.
97. Ponce G, Perez-Gonzalez R, Aragues M, Palomo T, Rodriguez-Jimenez R, Jimenez-Arriero MA et al. The ANKK1 kinase gene and psychiatric disorders. Neurotox Res 2009;16:50-59.
98. Yang BZ, Kranzler HR, Zhao H, Gruen JR, Luo X, Gelernter J. Haplotypic variants in DRD2, ANKK1, TTC12, and NCAM1 are associated with comorbid alcohol and drug dependence. Alcohol Clin Exp Res 2008;32:2117-2127.
99. Sipila T, Kananen L, Greco D, Donner J, Silander K, Terwilliger JD et al. An association analysis of circadian genes in anxiety disorders. Biol Psychiatry 2010;67:1163-1170.
100. Massat I, Souery D, Del-Favero J, Van Gestel S, Serretti A, Macciardi F et al. Positive association of dopamine D2 receptor polymorphism with bipolar affective disorder in a European Multicenter Association Study of affective disorders. Am J Med Genet 2002;114:177-185. (Pubitemid 34160469)
101. Maron E, Nikopensius T, Koks S, Altmae S, Heinaste E, Vabrit K et al. Association study of 90 candidate gene polymorphisms in panic disorder. Psychiatr Genet 2005;15:17-24. (Pubitemid 40411566)
102. Surget A, Wang Y, Leman S, Ibarguen-Vargas Y, Edgar N, Griebel G et al. Corticolimbic transcriptome changes are state-dependent and region-specific in a rodent model of depression and of antidepressant reversal. Neuropsychopharmacology 2009;34:1363-1380.
103. Iwamoto K, Bundo M, Yamamoto M, Ozawa H, Saito T, Kato T. Decreased expression of NEFH and PCP4/PEP19 in the prefrontal cortex of alcoholics. Neurosci Res 2004;49:379-385. (Pubitemid 38953855)
104. Miller GE, Chen E, Sze J, Marin T, Arevalo JM, Doll R et al. A functional genomic fingerprint of chronic stress in humans: blunted glucocorticoid and increased NF-kappaB signaling. Biol Psychiatry 2008;64:266-272.
105. Doyle AE, Biederman J, Ferreira MA, Wong P, Smoller JW, Faraone SV. Suggestive linkage of the child behavior checklist juvenile bipolar disorder phenotype to 1p21, 6p21, and 8q21. J Am Acad Child Adolesc Psychiatry 2010;49:378-387.
106. Nash MW, Huezo-Diaz P, Williamson RJ, Sterne A, Purcell S, Hoda F et al. Genome-wide linkage analysis of a composite index of neuroticism and mood-related scales in extreme selected sibships. Hum Mol Genet 2004;13:2173-2182. (Pubitemid 39359918)
107. Ishikawa M, Mizukami K, Iwakiri M, Asada T. Immunohistochemical and immunoblot analysis of Dopamine and cyclic AMP-regulated phosphoprotein, relative molecular mass 32, 000 (DARPP-32) in the prefrontal cortex of subjects with schizophrenia and bipolar disorder. Prog Neuropsychopharmacol Biol Psychiatry 2007;31:1177-1181. (Pubitemid 47081302)
108. Torres KC, Souza BR, Miranda DM, Nicolato R, Neves FS, Barros AG et al. The leukocytes expressing DARPP-32 are reduced in patients with schizophrenia and bipolar disorder. Prog Neuropsychopharmacol Biol Psychiatry 2009;33:214-219.
109. Tabakoff B, Saba L, Printz M, Flodman P, Hodgkinson C, Goldman D et al. Genetical genomic determinants of alcohol consumption in rats and humans. BMC Biol 2009;7:70.
110. Benes FM, Matzilevich D, Burke RE, Walsh J. The expression of proapoptosis genes is increased in bipolar disorder, but not in schizophrenia. Mol Psychiatry 2006;11:241-251.
111. Kawai T, Morita K, Masuda K, Nishida K, Shikishima M, Ohta M et al. Gene expression signature in peripheral blood cells from medical students exposed to chronic psychological stress. Biol Psychol 2007;76:147-155. (Pubitemid 47575788)
112. Fallin MD, Lasseter VK, Avramopoulos D, Nicodemus KK, Wolyniec PS, McGrath JA et al. Bipolar I disorder and schizophrenia: a 440-single-nucleotide polymorphism screen of 64 candidate genes among Ashkenazi Jewish case-parent trios. Am J Hum Genet 2005;77:918-936. (Pubitemid 41698514)
113. McQuillin A, Rizig M, Gurling HM. A microarray gene expression study of the molecular pharmacology of lithium carbonate on mouse brain mRNA to understand the neurobiology of mood stabilization and treatment of bipolar affective disorder. Pharmacogenet Genomics 2007;17:605-617. (Pubitemid 47057710)
114. Lewohl JM, Wang L, Miles MF, Zhang L, Dodd PR, Harris RA. Gene expression in human alcoholism: microarray analysis of frontal cortex. Alcohol Clin Exp Res 2000;24:1873-1882. (Pubitemid 32001860)
115. Cordeiro Q, Talkowski ME, Chowdari KV, Wood J, Nimgaonkar V, Vallada H. Association and linkage analysis of RGS4 polymorphisms with schizophrenia and bipolar disorder in Brazil. Genes Brain Behav 2005;4:45-50. (Pubitemid 40175418)
116. Bertsch B, Ogden CA, Sidhu K, Le-Niculescu H, Kuczenski R, Niculescu AB. Convergent functional genomics: a Bayesian candidate gene identification approach for complex disorders. Methods 2005;37:274-279. (Pubitemid 41660872)
117. Aston C, Jiang L, Sokolov BP. Transcriptional profiling reveals evidence for signaling and oligodendroglial abnormalities in the temporal cortex from patients with major depressive disorder. Mol Psychiatry 2005;10:309-322. (Pubitemid 40432684)
118. Middleton FA, Pato CN, Gentile KL, McGann L, Brown AM, Trauzzi M et al. Gene expression analysis of peripheral blood leukocytes from discordant sib-pairs with schizophrenia and bipolar disorder reveals points of convergence between genetic and functional genomic approaches. Am J Med Genet B Neuropsychiatr Genet 2005;136:12-25. (Pubitemid 40917523)
119. Zubenko GS, Maher B, Hughes III HB, Zubenko WN, Stiffler JS, Kaplan BB et al. Genome-wide linkage survey for genetic loci that influence the development of depressive disorders in families with recurrent, early-onset, major depression. Am J Med Genet B Neuropsychiatr Genet 2003;123:1-18. (Pubitemid 37323257)
120. Cassidy F, Zhao C, Badger J, Claffey E, Dobrin S, Roche S et al. Genome-wide scan of bipolar disorder and investigation of population stratification effects on linkage: support for susceptibility loci at 4q21, 7q36, 9p21, 12q24, 14q24, and 16p13. Am J Med Genet B Neuropsychiatr Genet 2007;144 B: 791-801. (Pubitemid 47417209)
121. Goes FS, Zandi PP, Miao K, McMahon FJ, Steele J, Willour VL et al. Mood-incongruent psychotic features in bipolar disorder: familial aggregation and suggestive linkage to 2p11-q14 and 13q21-33. Am J Psychiatry 2007;164:236-247.
122. Rogers PJ, Hohoff C, Heatherley SV, Mullings EL, Maxfield PJ, Evershed RP et al. Association of the anxiogenic and alerting effects of caffeine with ADORA2A and ADORA1 polymorphisms and habitual level of caffeine consumption. Neuropsychopharmacology 2010;35:1973-1983.
123. Maron E, Kallassalu K, Tammiste A, Kolde R, Vilo J, Toru I et al. Peripheral gene expression profiling of CCK-4-induced panic in healthy subjects. Am J Med Genet B Neuropsychiatr Genet 2010;153 B: 269-274.
124. Deckert J, Nothen MM, Franke P, Delmo C, Fritze J, Knapp M et al. Systematic mutation screening and association study of the A1 and A2a adenosine receptor genes in panic disorder suggest a contribution of the A2a gene to the development of disease. Mol Psychiatry 1998;3:81-85. (Pubitemid 28045190)
125. Hamilton SP, Slager SL, De Leon AB, Heiman GA, Klein DF, Hodge SE et al. Evidence for genetic linkage between a polymorphism in the adenosine 2A receptor and panic disorder. Neuropsychopharmacology 2004;29:558-565. (Pubitemid 38365933)
126. Barley K, Dracheva S, Byne W. Subcortical oligodendrocyte-and astrocyte-associated gene expression in subjects with schizophrenia, major depression and bipolar disorder. Schizophr Res 2009;112:54-64.
127. Detera-Wadleigh SD, Badner JA, Berrettini WH, Yoshikawa T, Goldin LR, Turner G et al. A high-density genome scan detects evidence for a bipolar-disorder susceptibility locus on 13q32 and other potential loci on 1q32 and 18p11.2. Proc Natl Acad Sci USA 1999;96:5604-5609. (Pubitemid 29234665)
128. Liang KY, Wang Y, Shugart YY, Grados M, Fyer AJ, Rauch S et al. Evidence for potential relationship between SLC1A1 and a putative genetic linkage region on chromosome 14q to obsessive-compulsive disorder with compulsive hoarding. Am J Med Genet B Neuropsychiatr Genet 2008;147 B: 1000-1002.
129. Gelernter J, Page GP, Bonvicini K, Woods SW, Pauls DL, Kruger S. A chromosome 14 risk locus for simple phobia: results from a genomewide linkage scan. Mol Psychiatry 2003;8:71-82. (Pubitemid 36188575)
130. Pennington K, Beasley CL, Dicker P, Fagan A, English J, Pariante CM et al. Prominent synaptic and metabolic abnormalities revealed by proteomic analysis of the dorsolateral prefrontal cortex in schizophrenia and bipolar disorder. Mol Psychiatry 2008;13:1102-1117.
131. Seelan RS, Khalyfa A, Lakshmanan J, Casanova MF, Parthasarathy RN. Deciphering the lithium transcriptome: microarray profiling of lithium-modulated gene expression in human neuronal cells. Neuroscience 2008;151:1184-1197.
132. Fullerton JM, Donald JA, Mitchell PB, Schofield PR. Two-dimensional genome scan identifies multiple genetic interactions in bipolar affective disorder. Biol Psychiatry 2010;67:478-486.
133. Lambert D, Middle F, Hamshere ML, Segurado R, Raybould R, Corvin A et al. Stage 2 of the Wellcome Trust UK-Irish bipolar affective disorder sibling-pair genome screen: evidence for linkage on chromosomes 6q16-q21, 4q12-q21, 9p21, 10p14-p12 and 18q22. Mol Psychiatry 2005;10:831-841. (Pubitemid 43080117)
134. Foroud T, Bice P, Castelluccio P, Bo R, Miller L, Ritchotte A et al. Identification of quantitative trait loci influencing alcohol consumption in the high alcohol drinking and low alcohol drinking rat lines. Behav Genet 2000;30:131-140. (Pubitemid 30660645)
135. Conti B, Maier R, Barr AM, Morale MC, Lu X, Sanna PP et al. Region-specific transcriptional changes following the three antidepressant treatments electro convulsive therapy, sleep deprivation and fluoxetine. Mol Psychiatry 2007;12:167-189. (Pubitemid 46160982)
136. Liu J, Lewohl JM, Harris RA, Iyer VR, Dodd PR, Randall PK et al. Patterns of gene expression in the frontal cortex discriminate alcoholic from nonalcoholic individuals. Neuropsychopharmacology 2006;31:1574-1582.
137. Bergen AW, Yang XR, Bai Y, Beerman MB, Goldstein AM, Goldin LR. Genomic regions linked to alcohol consumption in the Framingham Heart Study. BMC Genet 2003;4(Suppl 1):S101.
138. Thorgeirsson TE, Oskarsson H, Desnica N, Kostic JP, Stefansson JG, Kolbeinsson H et al. Anxiety with panic disorder linked to chromosome 9q in Iceland. Am J Hum Genet 2003;72:1221-1230. (Pubitemid 36530009)
139. Wang SS, Kamphuis W, Huitinga I, Zhou JN, Swaab DF. Gene expression analysis in the human hypothalamus in depression by laser microdissection and real-time PCR: the presence of multiple receptor imbalances. Mol Psychiatry 2008;13:786-799, 741.
140. Treutlein J, Cichon S, Ridinger M, Wodarz N, Soyka M, Zill P et al. Genome-wide association study of alcohol dependence. Arch Gen Psychiatry 2009;66:773-784.
141. Mill J, Kiss E, Baji I, Kapornai K, Daroczy G, Vetro A et al. Association study of the estrogen receptor alpha gene (ESR1) and childhood-onset mood disorders. Am J Med Genet B Neuropsychiatr Genet 2008;147 B: 1323-1326.
142. Wang H, Zhu YZ, Wong PT, Farook JM, Teo AL, Lee LK et al. cDNA microarray analysis of gene expression in anxious PVG and SD rats after cat-freezing test. Exp Brain Res 2003;149:413-421. (Pubitemid 36458031)
143. Klempan TA, Rujescu D, Merette C, Himmelman C, Sequeira A, Canetti L et al. Profiling brain expression of the spermidine/spermine N1-acetyltransferase 1 (SAT1) gene in suicide. Am J Med Genet B Neuropsychiatr Genet 2009;150 B: 934-943.
144. Maziade M, Roy MA, Chagnon YC, Cliche D, Fournier JP, Montgrain N et al. Shared and specific susceptibility loci for schizophrenia and bipolar disorder: a dense genome scan in Eastern Quebec families. Mol Psychiatry 2005;10:486-499. (Pubitemid 40646437)
145. Erhardt A, Czibere L, Roeske D, Lucae S, Unschuld PG, Ripke S et al. TMEM132D, a new candidate for anxiety phenotypes: evidence from human and mouse studies. Mol Psychiatry; advance online publication, 6 April 2010 [e-pub ahead of print].
146. Bilkei-Gorzo A, Racz I, Michel K, Zimmer A, Klingmuller D, Zimmer A. Behavioral phenotype of pre-proenkephalin-deficient mice on diverse congenic backgrounds. Psychopharmacology (Berl) 2004;176:343-352. (Pubitemid 40012741)
147. Palo OM, Soronen P, Silander K, Varilo T, Tuononen K, Kieseppa T et al. Identification of susceptibility loci at 7q31 and 9p13 for bipolar disorder in an isolated population. Am J Med Genet B Neuropsychiatr Genet 2010;153 B: 723-735.
148. Kim KS, Han PL. Optimization of chronic stress paradigms using anxiety-and depressionlike behavioral parameters. J Neurosci Res 2006;83:497-507.
149. Sherva R, Rice JP, Neuman RJ, Rochberg N, Saccone NL, Bierut LJ. Associations and interactions between SNPs in the alcohol metabolizing genes and alcoholism phenotypes in European Americans. Alcohol Clin Exp Res 2009;33:848-857.
150. Sequeira A, Klempan T, Canetti L, ffrench-Mullen J, Benkelfat C, Rouleau GA et al. Patterns of gene expression in the limbic system of suicides with and without major depression. Mol Psychiatry 2007;12:640-655. (Pubitemid 46998251)
151. Shyn SI, Shi J, Kraft JB, Potash JB, Knowles JA, Weissman MM et al. Novel loci for major depression identified by genome-wide association study of Sequenced Treatment Alternatives to Relieve Depression and meta-analysis of three studies. Mol Psychiatry 2011;16:202-215.
152. Sherrin T, Blank T, Saravana R, Rayner M, Spiess J, Todorovic C. Region specific gene expression profile in mouse brain after chronic corticotropin releasing factor receptor 1 activation: the novel role for diazepam binding inhibitor in contextual fear conditioning. Neuroscience 2009;162:14-22.
153. Fallin MD, Lasseter VK, Wolyniec PS, McGrath JA, Nestadt G, Valle D et al. Genomewide linkage scan for bipolar-disorder susceptibility loci among Ashkenazi Jewish families. Am J Hum Genet 2004;75:204-219. (Pubitemid 38943864)
154. McBride WJ, Kimpel MW, Schultz JA, McClintick JN, Edenberg HJ, Bell RL. Changes in gene expression in regions of the extended amygdala of alcohol-preferring rats after binge-like alcohol drinking. Alcohol 2010;44:171-183.
155. Park N, Juo SH, Cheng R, Liu J, Loth JE, Lilliston B et al. Linkage analysis of psychosis in bipolar pedigrees suggests novel putative loci for bipolar disorder and shared susceptibility with schizophrenia. Mol Psychiatry 2004;9:1091-1099. (Pubitemid 40065454)
156. Schulze TG, Buervenich S, Badner JA, Steele CJ, Detera-Wadleigh SD, Dick D et al. Loci on chromosomes 6q and 6p interact to increase susceptibility to bipolar affective disorder in the national institute of mental health genetics initiative pedigrees. Biol Psychiatry 2004;56:18-23. (Pubitemid 38813401)
157. Sun F, Cheng R, Flanders WD, Yang Q, Khoury MJ. Whole genome association studies for genes affecting alcohol dependence. Genet Epidemiol 1999;17(Suppl 1):S337-S342.
158. Liebl C, Panhuysen M, Putz B, Trumbach D, Wurst W, Deussing JM et al. Gene expression profiling following maternal deprivation: involvement of the brain Renin-Angiotensin system. Front Mol Neurosci 2009;2:1.
159. Beasley CL, Pennington K, Behan A, Wait R, Dunn MJ, Cotter D. Proteomic analysis of the anterior cingulate cortex in the major psychiatric disorders: evidence for diseaseassociated changes. Proteomics 2006;6:3414-3425. (Pubitemid 43886157)
160. Bernard R, Kerman IA, Thompson RC, Jones EG, Bunney WE, Barchas JD et al. Altered expression of glutamate signaling, growth factor, and glia genes in the locus coeruleus of patients with major depression. Mol Psychiatry; advance online publication, 13 April 2010 [e-pub ahead of print].
161. Dick DM, Nurnberger Jr J, Edenberg HJ, Goate A, Crowe R, Rice J et al. Suggestive linkage on chromosome 1 for a quantitative alcohol-related phenotype. Alcohol Clin Exp Res 2002;26:1453-1460. (Pubitemid 35192305)
162. Mozhui K, Karlsson RM, Kash TL, Ihne J, Norcross M, Patel S et al. Strain differences in stress responsivity are associated with divergent amygdala gene expression and glutamate-mediated neuronal excitability. J Neurosci 2010;30:5357-5367.
163. Orsetti M, Di Brisco F, Rinaldi M, Dallorto D, Ghi P. Some molecular effectors of antidepressant action of quetiapine revealed by DNA microarray in the frontal cortex of anhedonic rats. Pharmacogenet Genomics 2009;19:600-612.
164. Ising M, Lucae S, Binder EB, Bettecken T, Uhr M, Ripke S et al. A genomewide association study points to multiple loci that predict antidepressant drug treatment outcome in depression. Arch Gen Psychiatry 2009;66:966-975.
165. Brandish PE, Su M, Holder DJ, Hodor P, Szumiloski J, Kleinhanz RR et al. Regulation of gene expression by lithium and depletion of inositol in slices of adult rat cortex. Neuron 2005;45:861-872. (Pubitemid 40395265)
166. Hill SY, Shen S, Zezza N, Hoffman EK, Perlin M, Allan W. A genome wide search for alcoholism susceptibility genes. Am J Med Genet B Neuropsychiatr Genet 2004;128:102-113. (Pubitemid 38849928)
167. Pato CN, Pato MT, Kirby A, Petryshen TL, Medeiros H, Carvalho C et al. Genome-wide scan in Portuguese Island families implicates multiple loci in bipolar disorder: fine mapping adds support on chromosomes 6 and 11. Am J Med Genet B Neuropsychiatr Genet 2004;127 B: 30-34. (Pubitemid 38542309)
168. Choudary PV, Molnar M, Evans SJ, Tomita H, Li JZ, Vawter MP et al. Altered cortical glutamatergic and GABAergic signal transmission with glial involvement in depression. Proc Natl Acad Sci USA 2005;102:15653-15658. (Pubitemid 41528111)
169. Mitsuyama H, Little KY, Sieghart W, Devaud LL, Morrow AL. GABA (A) receptor alpha1, alpha4, and beta3 subunit mRNA and protein expression in the frontal cortex of human alcoholics. Alcohol Clin Exp Res 1998;22:815-822. (Pubitemid 28292464)
170. Song J, Koller DL, Foroud T, Carr K, Zhao J, Rice J et al. Association of GABA (A) receptors and alcohol dependence and the effects of genetic imprinting. Am J Med Genet B Neuropsychiatr Genet 2003;117:39-45. (Pubitemid 37059358)
171. Craddock N, Jones L, Jones IR, Kirov G, Green EK, Grozeva D et al. Strong genetic evidence for a selective influence of GABA (A) receptors on a component of the bipolar disorder phenotype. Mol Psychiatry 2010;15:146-153.
172. Lind PA, Macgregor S, Vink JM, Pergadia ML, Hansell NK, de Moor MH et al. A genomewide association study of nicotine and alcohol dependence in Australian and Dutch populations. Twin Res Hum Genet 2010;13:10-29.
173. O'Dushlaine C, Kenny E, Heron E, Donohoe G, Gill M, Morris D et al. Molecular pathways involved in neuronal cell adhesion and membrane scaffolding contribute to schizophrenia and bipolar disorder susceptibility. Mol Psychiatry 2011;16:286-292.
174. Smoller JW, Acierno Jr JS, Rosenbaum JF, Biederman J, Pollack MH, Meminger S et al. Targeted genome screen of panic disorder and anxiety disorder proneness using homology to murine QTL regions. Am J Med Genet 2001;105:195-206. (Pubitemid 32290587)
175. Meira-Lima IV, Pereira AC, Mota GF, Krieger JE, Vallada H. Angiotensinogen and angiotensin converting enzyme gene polymorphisms and the risk of bipolar affective disorder in humans. Neurosci Lett 2000;293:103-106.
176. Su YA, Wu J, Zhang L, Zhang Q, Su DM, He P et al. Dysregulated mitochondrial genes and networks with drug targets in postmortem brain of patients with posttraumatic stress disorder (PTSD) revealed by human mitochondria-focused cDNA microarrays. Int J Biol Sci 2008;4:223-235.
177. Xuei X, Flury-Wetherill L, Almasy L, Bierut L, Tischfield J, Schuckit M et al. Association analysis of genes encoding the nociceptin receptor (OPRL1) and its endogenous ligand (PNOC) with alcohol or illicit drug dependence. Addict Biol 2008;13:80-87. (Pubitemid 351202134)
178. Kohen R, Kirov S, Navaja GP, Happe HK, Hamblin MW, Snoddy JR et al. Gene expression profiling in the hippocampus of learned helpless and nonhelpless rats. Pharmacogenomics J 2005;5:278-291. (Pubitemid 41486228)
179. Worst TJ, Tan JC, Robertson DJ, Freeman WM, Hyytia P, Kiianmaa K et al. Transcriptome analysis of frontal cortex in alcohol-preferring and nonpreferring rats. J Neurosci Res 2005;80:529-538. (Pubitemid 40780813)
180. Flatscher-Bader T, van der Brug M, Hwang JW, Gochee PA, Matsumoto I, Niwa S et al. Alcohol-responsive genes in the frontal cortex and nucleus accumbens of human alcoholics. J Neurochem 2005;93:359-370. (Pubitemid 40547493)
181. Ryan MM, Lockstone HE, Huffaker SJ, Wayland MT, Webster MJ, Bahn S. Gene expression analysis of bipolar disorder reveals downregulation of the ubiquitin cycle and alterations in synaptic genes. Mol Psychiatry 2006;11:965-978. (Pubitemid 44470218)
182. Morissette J, Villeneuve A, Bordeleau L, Rochette D, Laberge C, Gagne B et al. Genomewide search for linkage of bipolar affective disorders in a very large pedigree derived from a homogeneous population in quebec points to a locus of major effect on chromosome 12q23-q24. Am J Med Genet 1999;88:567-587. (Pubitemid 29485088)
183. Weissman MM, Fyer AJ, Haghighi F, Heiman G, Deng Z, Hen R et al. Potential panic disorder syndrome: clinical and genetic linkage evidence. Am J Med Genet 2000;96:24-35. (Pubitemid 30077646)
184. Soria V, Martinez-Amoros E, Escaramis G, Valero J, Perez-Egea R, Garcia C et al. Differential association of circadian genes with mood disorders: CRY1 and NPAS2 are associated with unipolar major depression and CLOCK and VIP with bipolar disorder. Neuropsychopharmacology 2010;35:1279-1289.
185. Maron E, Hettema JM, Shlik J. Advances in molecular genetics of panic disorder. Mol Psychiatry 2010;15:681-701.
186. Luciano M, Houlihan LM, Harris SE, Gow AJ, Hayward C, Starr JM et al. Association of existing and new candidate genes for anxiety, depression and personality traits in older people. Behav Genet 2010;40:518-532.
187. Hamilton SP, Fyer AJ, Durner M, Heiman GA, Baisre de Leon A, Hodge SE et al. Further genetic evidence for a panic disorder syndrome mapping to chromosome 13q. Proc Natl Acad Sci USA 2003;100:2550-2555. (Pubitemid 36297536)
188. Fyer AJ, Hamilton SP, Durner M, Haghighi F, Heiman GA, Costa R et al. A third-pass genome scan in panic disorder: evidence for multiple susceptibility loci. Biol Psychiatry 2006;60:388-401. (Pubitemid 44215850)
189. Ishikawa M, Mizukami K, Iwakiri M, Hidaka S, Asada T. Immunohistochemical and immunoblot study of GABA (A) alpha1 and beta2/3 subunits in the prefrontal cortex of subjects with schizophrenia and bipolar disorder. Neurosci Res 2004;50:77-84. (Pubitemid 39024304)
190. Johnson C, Drgon T, McMahon FJ, Uhl GR. Convergent genome wide association results for bipolar disorder and substance dependence. Am J Med Genet B Neuropsychiatr Genet 2009;150 B: 182-190.
191. Xing G, Zhang L, Russell S, Post R. Reduction of dopamine-related transcription factors Nurr1 and NGFI-B in the prefrontal cortex in schizophrenia and bipolar disorders. Schizophr Res 2006;84:36-56.
192. Etheridge N, Lewohl JM, Mayfield RD, Harris RA, Dodd PR. Synaptic proteome changes in the superior frontal gyrus and occipital cortex of the alcoholic brain. Proteomics Clin Appl 2009;3:730-742.
193. Dick DM, Aliev F, Bierut L, Goate A, Rice J, Hinrichs A et al. Linkage analyses of IQ in the collaborative study on the genetics of alcoholism (COGA) sample. Behav Genet 2006;36:77-86.
194. Benes FM, Todtenkopf MS, Logiotatos P, Williams M. Glutamate decarboxylase (65) - immunoreactive terminals in cingulate and prefrontal cortices of schizophrenic and bipolar brain. J Chem Neuroanat 2000;20:259-269. (Pubitemid 32162885)
195. Heckers S, Stone D, Walsh J, Shick J, Koul P, Benes FM. Differential hippocampal expression of glutamic acid decarboxylase 65 and 67 messenger RNA in bipolar disorder and schizophrenia. Arch Gen Psychiatry 2002;59:521-529. (Pubitemid 34602934)
196. Lappalainen J, Krupitsky E, Kranzler HR, Luo X, Remizov M, Pchelina S et al. Mutation screen of the GAD2 gene and association study of alcoholism in three populations. Am J Med Genet B Neuropsychiatr Genet 2007;144 B: 183-192. (Pubitemid 46606643)
197. Unschuld PG, Ising M, Specht M, Erhardt A, Ripke S, Heck A et al. Polymorphisms in the GAD2 gene-region are associated with susceptibility for unipolar depression and with a risk factor for anxiety disorders. Am J Med Genet B Neuropsychiatr Genet 2009;150 B: 1100-1109.
198. Martin MV, Rollins B, Sequeira PA, Mesen A, Byerley W, Stein R et al. Exon expression in lymphoblastoid cell lines from subjects with schizophrenia before and after glucose deprivation. BMC Med Genomics 2009;2:62.
199. Schuckit MA, Edenberg HJ, Kalmijn J, Flury L, Smith TL, Reich T et al. A genome-wide search for genes that relate to a low level of response to alcohol. Alcohol Clin Exp Res 2001;25:323-329. (Pubitemid 32221810)
200. Karssen AM, Her S, Li JZ, Patel PD, Meng F, Bunney Jr WE et al. Stress-induced changes in primate prefrontal profiles of gene expression. Mol Psychiatry 2007;12:1089-1102. (Pubitemid 350191369)
201. Derijk RH, van Leeuwen N, Klok MD, Zitman FG. Corticosteroid receptor-gene variants: modulators of the stress-response and implications for mental health. Eur J Pharmacol 2008;585:492-501.
202. Weaver IC, Meaney MJ, Szyf M. Maternal care effects on the hippocampal transcriptome and anxiety-mediated behaviors in the offspring that are reversible in adulthood. Proc Natl Acad Sci USA 2006;103:3480-3485. (Pubitemid 43346494)
203. Jurata LW, Bukhman YV, Charles V, Capriglione F, Bullard J, Lemire AL et al. Comparison of microarray-based mRNA profiling technologies for identification of psychiatric disease and drug signatures. J Neurosci Methods 2004;138:173-188. (Pubitemid 39485990)
204. Youngs RM, Chu MS, Meloni EG, Naydenov A, Carlezon Jr WA, Konradi C. Lithium administration to preadolescent rats causes long-lasting increases in anxiety-like behavior and has molecular consequences. J Neurosci 2006;26:6031-6039. (Pubitemid 44318369)
205. McNamara RK, Ostrander M, Abplanalp W, Richtand NM, Benoit SC, Clegg DJ. Modulation of phosphoinositide-protein kinase C signal transduction by omega-3 fatty acids: implications for the pathophysiology and treatment of recurrent neuropsychiatric illness. Prostaglandins Leukot Essent Fatty Acids 2006;75:237-257. (Pubitemid 44442916)
206. Pandey GN, Dwivedi Y, Ren X, Rizavi HS, Roberts RC, Conley RR et al. Altered expression and phosphorylation of myristoylated alanine-rich C kinase substrate (MARCKS) in postmortem brain of suicide victims with or without depression. J Psychiatr Res 2003;37:421-432. (Pubitemid 36808815)
207. Hattori E, Toyota T, Ishitsuka Y, Iwayama Y, Yamada K, Ujike H et al. Preliminary genome-wide association study of bipolar disorder in the Japanese population. Am J Med Genet B Neuropsychiatr Genet 2009;150 B: 1110-1117.
208. Chu TT, Liu Y, Kemether E. Thalamic transcriptome screening in three psychiatric states. J Hum Genet 2009;54:665-675.
209. Maron E, Hettema JM, Shlik J. Advances in molecular genetics of panic disorder. Mol Psychiatry 2010;15:681-701.
210. Stopkova P, Saito T, Fann CS, Papolos DF, Vevera J, Paclt I et al. Polymorphism screening of PIP5K2A: a candidate gene for chromosome 10p-linked psychiatric disorders. Am J Med Genet B Neuropsychiatr Genet 2003;123 B: 50-58. (Pubitemid 37323263)
211. Wray NR, James MR, Mah SP, Nelson M, Andrews G, Sullivan PF et al. Anxiety and comorbid measures associated with PLXNA2. Arch Gen Psychiatry 2007;64:318-326. (Pubitemid 46376783)
212. Curtis D, Kalsi G, Brynjolfsson J, McInnis M, O'Neill J, Smyth C et al. Genome scan of pedigrees multiply affected with bipolar disorder provides further support for the presence of a susceptibility locus on chromosome 12q23-q24, and suggests the presence of additional loci on 1p and 1q. Psychiatr Genet 2003;13:77-84. (Pubitemid 36724535)
213. Gelernter J, Bonvicini K, Page G, Woods SW, Goddard AW, Kruger S et al. Linkage genome scan for loci predisposing to panic disorder or agoraphobia. Am J Med Genet 2001;105:548-557. (Pubitemid 32729824)
214. Foroud T, Bucholz KK, Edenberg HJ, Goate A, Neuman RJ, Porjesz B et al. Linkage of an alcoholism-related severity phenotype to chromosome 16. Alcohol Clin Exp Res 1998;22:2035-2042. (Pubitemid 29031022)
215. Macgregor S, Visscher PM, Knott SA, Thomson P, Porteous DJ, Millar JK et al. A genome scan and follow-up study identify a bipolar disorder susceptibility locus on chromosome 1q42. Mol Psychiatry 2004;9:1083-1090. (Pubitemid 40065453)
216. Nakatani N, Ohnishi T, Iwamoto K, Watanabe A, Iwayama Y, Yamashita S et al. Expression analysis of actin-related genes as an underlying mechanism for mood disorders. Biochem Biophys Res Commun 2007;352:780-786. (Pubitemid 44883370)
217. Del Zompo M, Severino G, Ardau R, Chillotti C, Piccardi M, Dib C et al. Genome-scan for bipolar disorder with sib-pair families in the Sardinian population: a new susceptibility locus on chromosome 1p22-p21? Am J Med Genet B Neuropsychiatr Genet 2010;153 B: 1200-1208.
218. Nurnberger Jr JI, Foroud T, Flury L, Su J, Meyer ET, Hu K et al. Evidence for a locus on chromosome 1 that influences vulnerability to alcoholism and affective disorder. Am J Psychiatry 2001;158:718-724. (Pubitemid 32429838)
219. Zandi PP, Badner JA, Steele J, Willour VL, Miao K, MacKinnon DF et al. Genome-wide linkage scan of 98 bipolar pedigrees and analysis of clinical covariates. Mol Psychiatry 2007;12:630-639. (Pubitemid 46998258)
220. Bailer U, Leisch F, Meszaros K, Lenzinger E, Willinger U, Strobl R et al. Genome scan for susceptibility loci for schizophrenia and bipolar disorder. Biol Psychiatry 2002;52:40-52. (Pubitemid 34655555)
221. Sousa JC, Grandela C, Fernandez-Ruiz J, de Miguel R, de Sousa L, Magalhaes AI et al. Transthyretin is involved in depression-like behaviour and exploratory activity. J Neurochem 2004;88:1052-1058. (Pubitemid 38280673)